CFX96™ IVD Real-Time PCR Systems offer the ultimate flexibility in commercial assay selection or rapid assay development in a clinical laboratory setting. The instruments offer precise quantification and target discrimination for up to five targets, with accurate thermal cycler performance and powerful easy-to-use software.
|10–50 µl reaction volumes
||10–125 µl reaction volumes
|Up to 5-target multiplexing for reduced sample and reagent use
|Quickly and accurately analyze and validate data using the intuitive CFX Manager™ IVD Software
The CFX96 Real-Time PCR Detection System—IVD is intended for use in the fields of research and human in vitro diagnostics. The system is CE-IVD marked in compliance with the European Union diagnostic medical device manufacturing standards.
Europe: For in vitro diagnostic use. The CFX96 Real-Time PCR Detection System—IVD and CFX96 Deep Well Real-Time PCR Detection System—IVD meet the requirements of the In Vitro Diagnostic Medical Devices Directive (98/79/EC). The CE IVD–registered CFX96 Real-Time PCR Detection System—IVD and CFX96 Deep Well IVD Real-Time Detection PCR System—IVD Instruments are for distribution and use in specific European countries only (Austria, Belgium, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden).
USA: The CFX96 Real-Time Detection System—IVD and CFX96 Deep Well Real-Time Detection System—IVD are not available for sale in the U.S.A.
No rights are granted by Bio-Rad for the use of melt curve analysis in the field of human in vitro diagnostics. In addition, it is the responsiblity of the purchaser to obtain any intellectual property rights which may be required for its specific applications.